Jason P. Rhodes
2013
In 2013, Jason P. Rhodes earned a total compensation of $3.2M as President and Chief Financial Officer at Epizyme, a 533% increase compared to previous year.
Compensation breakdown
| Bonus | $149,166 |
|---|---|
| Option Awards | $2,658,467 |
| Salary | $364,026 |
| Other | $1,467 |
| Total | $3,173,126 |
Rhodes received $2.7M in option awards, accounting for 84% of the total pay in 2013.
Rhodes also received $149.2K in bonus, $364K in salary and $1.5K in other compensation.
Rankings
In 2013, Jason P. Rhodes' compensation ranked 2,373rd out of 12,286 executives tracked by ExecPay. In other words, Rhodes earned more than 80.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,373 out of 12,286 | 81st |
Division Manufacturing | 790 out of 4,612 | 83rd |
Major group Chemicals And Allied Products | 214 out of 1,462 | 85th |
Industry group Drugs | 142 out of 1,156 | 88th |
Industry Pharmaceutical Preparations | 120 out of 890 | 87th |
Source: SEC filing on April 30, 2014.
Rhodes' colleagues
We found three more compensation records of executives who worked with Jason P. Rhodes at Epizyme in 2013.